Menu

Balchem Corporation BCPC

Full chart Compare
Set alert

Price alert · BCPC

All alert types
175.15 USD -0.84 (-0.48%)

Nov 10, 2026, 10:16 AM EST

174.53 Day range 177.40
147.18 52-week range 186.15
YTD
+14.21%
1 year
+12.83%
Market cap
5.61B
Revenue (ttm)
1.11B
Profit margin
15.41%
EPS (ttm)
5.30
Shares out
31.88M
P/E ratio
33.19
Forward P/E
27.65
Dividend
0.96 (0.55%)
Ex-dividend date
Dec 22, 2025
YTD return
+14.21%
1-year return
+12.83%
Volume
53.69K
Avg volume
244.58K
Open
175.15
Previous close
175.99
Day's range
174.53 – 177.40
52-week range
147.18 – 186.15
Beta
0.85
Analysts
Buy
Price target
213.50 (+21.9%)
Earnings date
Feb 19, 2027

 

No chart data for this range yet.

Key statistics

Enterprise value
5.62B
PEG ratio
2.98
Price / sales
5.06
Price / book
4.22
Dividend yield
0.55%
Payout ratio
18.11%
Revenue growth
8.60%
Free cash flow
139.50M
Total cash
66.26M
Total debt
142.44M
Return on equity
13.02%
Short % of float
2.23%
50-day average
169.99
200-day average
169.52

Financials — quick view

All financials
BCPC Revenue — quarterly 290.66M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
BCPC Net income — quarterly 46.73M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
BCPC EPS — quarterly 1.47
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

BCPC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 19, 2027Dec 30, 20261.41———
Oct 23, 2026Sep 30, 20261.431.57+0.14+9.79%
Jul 31, 2026Jun 30, 20261.271.40+0.13+10.24%
Apr 30, 2026Mar 31, 20261.331.25-0.08-6.02%
Feb 20, 2026Dec 31, 20251.291.31+0.02+1.55%
Oct 21, 2025Sep 30, 20251.361.35-0.01-0.74%

Upgrades / downgrades

BCPC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 23, 2026HC Wainwright & Co.mainBuyBuy
Aug 3, 2026HC Wainwright & Co.mainBuyBuy
May 4, 2026HC Wainwright & Co.mainBuyBuy
Feb 24, 2026HC Wainwright & Co.mainBuyBuy
Dec 5, 2025Rothschild & Coinit—Neutral
Oct 22, 2025HC Wainwright & Co.mainBuyBuy

About Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Sector
Basic Materials
Industry
Specialty Chemicals
Country
United States
Website
balchem.com

News

Your note

Sign in to keep a note on BCPC — it syncs with the Stock Master app.

Insider holders

BCPC insider holders
InsiderRelationLatest transactionDateShares held
BACKUS WILLIAM AOfficerStock Award(Grant)Feb 10, 20267,019
BENGTSSON CARL MARTINChief Financial OfficerStock Award(Grant)Feb 10, 202629,012
BONED FREDERICOfficerStock Award(Grant)Feb 10, 20269,419
FISCHER DAVID BDirectorStock Award(Grant)Feb 10, 20268,859
HARRIS THEODORE LChief Executive OfficerStock Award(Grant)Feb 10, 202694,402
MIYATA HATSUKIOfficerStock Award(Grant)Feb 10, 20269,232

Institution ownership

BCPC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.62%4,964,479873.70MJun 29, 2026
Vanguard Portfolio Management LLC6.99%2,221,267390.92MJun 29, 2026
Vanguard Capital Management LLC4.55%1,445,369254.37MJun 29, 2026
State Street Corporation4.03%1,281,552225.54MJun 29, 2026
Geode Capital Management, LLC3.54%1,123,683197.76MSep 29, 2026
Conestoga Capital Advisors, LLC2.69%854,550150.39MSep 29, 2026

Fund ownership

BCPC fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.98%1,898,724334.16MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.21%1,018,611179.27MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.65%842,214148.22MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.32%737,004129.71MJun 29, 2026
First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers1.81%574,500101.11MSep 29, 2026
Conestoga Funds-Conestoga Small Cap Fund1.60%508,95089.57MJun 29, 2026